Pharmacokinetics and Bioavailability of Sarafloxacin Hydrochloride in Chickens
Daju Wang
Abstract
Daju Wang
Abstract
The pharmacokinetics and bioavailability of sarafloxacin hydrochloride,following intravenous and oral administration of single dose 10 mg sarafloxacin/kg,were determined in 8 healthy chickens weighing 1.66±0.11) kg(mean±s),respectively.The serum concentration of sarafloxacin was measured by HPLC method.Pharmacokinetic parameters were obtained by computer calculation.The results showed that:the serum concentration-time date of sarafloxacin were fitted with a two-compartment model for intravenous administration.The elimination hafe-life(t 1/2β),the total body clearance(CL B),the volume of distribution(V d) and the area under the curve(AUC),were 2.678±0.506 h,1.339±0.351 L/kg·h,5.159±1.554 L/kg and 7.853±1.731 mg/L·h,respectively.Following oral administration,the drug concentration-time best described by a one-compartment absorption open model,the absorption and elimination half-lives (t 1/2ka?t 1/ke),the peak serum concentration (C max) and the time to reach C max(T max) were 0.287±0.117 h,5.381±1.446 h,0.478±0.196 mg/L ,1.229±0.439 h and 4.060±1.178 mg/L·h,respectively.The bioavailability(F) ranged from 31.83 to 69.90 (51.70±15.00%)?
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The pharmacokinetics and bioavailability of sarafloxacin hydrochloride,following intravenous and oral administration of single dose 10 mg sarafloxacin/kg,were determined in 8 healthy chickens weighing 1.66±0.11) kg(mean±s),respectively.The serum concentration of sarafloxacin was measured by HPLC method.Pharmacokinetic parameters were obtained by computer calculation.The results showed that:the serum concentration-time date of sarafloxacin were fitted with a two-compartment model for intravenous administration.The elimination hafe-life(t 1/2β),the total body clearance(CL B),the volume of distribution(V d) and the area under the curve(AUC),were 2.678±0.506 h,1.339±0.351 L/kg·h,5.159±1.554 L/kg and 7.853±1.731 mg/L·h,respectively.Following oral administration,the drug concentration-time best described by a one-compartment absorption open model,the absorption and elimination half-lives (t 1/2ka?t 1/ke),the peak serum concentration (C max) and the time to reach C max(T max) were 0.287±0.117 h,5.381±1.446 h,0.478±0.196 mg/L ,1.229±0.439 h and 4.060±1.178 mg/L·h,respectively.The bioavailability(F) ranged from 31.83 to 69.90 (51.70±15.00%)?
Key concepts: Bioavailability, Pharmacokinetics, Absorption (acoustics), Oral administration, Pharmacology, Volume of distribution, High-performance liquid chromatography, Hydrochloride